Omniab Inc (OABI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OABI | TARA | GALT | ||
| Company | Omniab Inc | Artara Therapeutics Inc | Galectin Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.9200 | 5.50 | 4.01 | ||
| High | 1.9400 | 5.57 | 4.13 | ||
| Low | 1.8900 | 5.32 | 3.97 | ||
| Latest | 1.9000 | 5.36 | 4.08 | ||
| Change | -0.0300 | -0.19 | +0.03 | ||
| % Change | -1.55% | -3.42% | +0.74% | ||
| Volume | 385,600 | 421,900 | 283,800 | ||
| 20-Day Average Volume | 624,740 | 1,139,870 | 804,320 | ||
| Previous Close | 1.9300 | 5.55 | 4.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.9780 | 5.75 | 5.40 | ||
| 20-Day Raw Stochastic | 39.62% | 14.73% | 15.28% | ||
| 20-Day Relative Strength | 51.90 | 46.69 | 38.81 | ||
| Weighted Alpha | -35.27 | -16.32 | +139.44 | ||
| Today's Opinion | 56% Buy | 56% Buy | 16% Buy | ||
| Previous Opinion | 56% Buy | 56% Buy | 24% Buy | ||
| Last Month's Opinion | 24% Sell | 100% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.09% since 12/19/25 | +1.71% since 12/19/25 | -6.85% since 12/19/25 | ||
| Low | 1.8500 on 12/24/25 | 5.26 on 12/23/25 | 3.53 on 12/23/25 | ||
| High | 2.1450 on 12/22/25 | 5.57 on 12/29/25 | 4.42 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +4.97% since 11/28/25 | -27.37% since 11/28/25 | -28.80% since 11/28/25 | ||
| Low | 1.6900 on 12/02/25 | 5.03 on 12/18/25 | 3.53 on 12/23/25 | ||
| High | 2.2200 on 12/12/25 | 7.27 on 12/01/25 | 7.13 on 12/17/25 | ||
| 3-Month | |||||
| %Chg | +18.01% since 09/29/25 | +21.54% since 09/29/25 | -3.32% since 09/29/25 | ||
| Low | 1.3000 on 11/05/25 | 4.10 on 10/02/25 | 3.53 on 12/23/25 | ||
| High | 2.2200 on 12/12/25 | 7.82 on 11/24/25 | 7.13 on 12/17/25 | ||
| 6-Month | |||||
| %Chg | +11.76% since 06/27/25 | +86.11% since 06/27/25 | +75.11% since 06/27/25 | ||
| Low | 1.3000 on 11/05/25 | 2.77 on 07/02/25 | 2.07 on 07/08/25 | ||
| High | 2.2950 on 07/09/25 | 7.82 on 11/24/25 | 7.13 on 12/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 273,515 | 276,742 | 263,050 | ||
| Shares Outstanding, K | 143,955 | 51,631 | 64,473 | ||
| Annual Sales | 26,390,000 | 0 | 0 | ||
| Annual Net Income | -62,030,000 | -44,600,000 | -47,050,000 | ||
| Last Quarter Sales | 2,240,000 | 0 | 0 | ||
| Last Quarter Net Income | -16,530,000 | -13,260,000 | -8,180,000 | ||
| 60-Month Beta | 0.13 | 1.38 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 11/04/25 | -0.31 on 11/10/25 | -0.13 on 11/14/25 | ||
| Latest Earnings Date | 03/17/26 | 03/04/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||